Display Settings:

Format

Send to:

Choose Destination
    Orthopedics. 2005 Jul;28(7):651-4.

    The paradox of heparin-induced thrombocytopenia: future anticoagulation.

    Source

    University of Kentucky Chandler Medical Center, Lexington, Ky, USA.

    Abstract

    Heparin and low molecular weight heparin agents are frequently administered to postoperative orthopedic patients. In patients with a history of heparin-induced thrombocytopenia, alternative anticoagulant agents to heparin for prophylaxis and treatment must be considered. Unfortunately, the data is limited in this patient population. Upon transitioning from heparin-induced thrombocytopenia treatment with direct thrombin inhibitors, argatroban, or lepirudin, careful consideration must be taken to avoid further thrombotic complications.

    PMID:
    16119279
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk